NO991161L - TNF-<beta>-lignende protein for behandling av prostatacancer, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder - Google Patents

TNF-<beta>-lignende protein for behandling av prostatacancer, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder

Info

Publication number
NO991161L
NO991161L NO991161A NO991161A NO991161L NO 991161 L NO991161 L NO 991161L NO 991161 A NO991161 A NO 991161A NO 991161 A NO991161 A NO 991161A NO 991161 L NO991161 L NO 991161L
Authority
NO
Norway
Prior art keywords
tnf
beta
protein
treatment
nucleic acid
Prior art date
Application number
NO991161A
Other languages
English (en)
Other versions
NO324815B1 (no
NO991161D0 (no
Inventor
Mark Erlander
Shaoming Huang
Michael Jackson
Per Peterson
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO991161D0 publication Critical patent/NO991161D0/no
Publication of NO991161L publication Critical patent/NO991161L/no
Publication of NO324815B1 publication Critical patent/NO324815B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19991161A 1996-09-11 1999-03-10 Anvendelse av et TNF-beta-lignende protein, eller et DNA- eller RNA molekyl som koder for det samme, for fremstilling av et preparat for behandling av androgen-uavhengig prostatacancer NO324815B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2592396P 1996-09-11 1996-09-11
PCT/US1997/016191 WO1998011224A1 (en) 1996-09-11 1997-09-11 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods

Publications (3)

Publication Number Publication Date
NO991161D0 NO991161D0 (no) 1999-03-10
NO991161L true NO991161L (no) 1999-05-07
NO324815B1 NO324815B1 (no) 2007-12-10

Family

ID=21828810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991161A NO324815B1 (no) 1996-09-11 1999-03-10 Anvendelse av et TNF-beta-lignende protein, eller et DNA- eller RNA molekyl som koder for det samme, for fremstilling av et preparat for behandling av androgen-uavhengig prostatacancer

Country Status (12)

Country Link
US (1) US6107476A (no)
EP (1) EP0950105A1 (no)
JP (1) JP2001500732A (no)
KR (1) KR20000038040A (no)
CN (1) CN1233289A (no)
AU (1) AU735776B2 (no)
BR (1) BR9711763A (no)
CA (1) CA2265444C (no)
IL (2) IL128872A0 (no)
NO (1) NO324815B1 (no)
NZ (1) NZ334592A (no)
WO (1) WO1998011224A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521227B1 (en) 1999-11-18 2003-02-18 Peter L. Hudson Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US5994102A (en) 1994-12-15 1999-11-30 Human Genome Sciences, Inc. Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14
US6465181B2 (en) * 1999-03-25 2002-10-15 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
DE60032355T2 (de) * 1999-05-17 2007-04-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh NEUROPROTEKTIVE EIGENSCHAFTEN VON GDF-15, EINEM VERTRETER DER TGF-ß-SUPERFAMILIE
AU2001288770A1 (en) * 2000-09-08 2002-03-22 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US20070237713A1 (en) * 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
EP2830646B1 (en) 2012-03-27 2018-03-07 NGM Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
US9161966B2 (en) 2013-01-30 2015-10-20 Ngm Biopharmaceuticals, Inc. GDF15 mutein polypeptides
US9828415B2 (en) 2013-01-30 2017-11-28 Ngm Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
EP3174894B1 (en) 2014-07-30 2021-06-23 NGM Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
EP3701969A1 (en) 2014-10-31 2020-09-02 NGM Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
CA3016035A1 (en) 2016-03-31 2017-10-05 Ngm Biopharmaceuticals, Inc. Binding proteins and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
JPH07250688A (ja) * 1994-01-28 1995-10-03 Sagami Chem Res Center ＴＧＦ−βスーパーファミリー蛋白質をコードするヒト新規ｃＤＮＡ
JPH07258293A (ja) * 1994-03-23 1995-10-09 Asahi Chem Ind Co Ltd 新規な蛋白質ならびにその製造方法
WO1996018730A1 (en) * 1994-12-15 1996-06-20 Human Genome Sciences, Inc. Prostatic growth factor
AU711368B2 (en) * 1995-06-22 1999-10-14 St Vincent's Hospital Sydney Limited Novel TGF-beta like cytokine
EP0833912B1 (en) * 1995-06-22 2009-02-25 St Vincent's Hospital Sydney Limited Novel tgf-beta like cytokine
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14

Also Published As

Publication number Publication date
EP0950105A1 (en) 1999-10-20
CA2265444C (en) 2008-11-18
IL128872A (en) 2009-08-03
IL128872A0 (en) 2000-01-31
KR20000038040A (ko) 2000-07-05
AU735776B2 (en) 2001-07-12
CN1233289A (zh) 1999-10-27
NO324815B1 (no) 2007-12-10
WO1998011224A1 (en) 1998-03-19
BR9711763A (pt) 1999-08-24
JP2001500732A (ja) 2001-01-23
AU4344297A (en) 1998-04-02
CA2265444A1 (en) 1998-03-19
NO991161D0 (no) 1999-03-10
NZ334592A (en) 2000-10-27
US6107476A (en) 2000-08-22

Similar Documents

Publication Publication Date Title
NO991161L (no) TNF-&lt;beta&gt;-lignende protein for behandling av prostatacancer, og beslektede nukleinsyremolekyler, farmas°ytiske sammensetninger og metoder
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
ATE282434T1 (de) Eine zusammensetzung enthaltend eine detergenz und einen ein tumorsuppressorgen kodierenden, adenoviralen vektor
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
NO326660B1 (no) Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
WO2001072962A3 (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
AU4986700A (en) Tall-1 nucleic acid molecules, proteins, receptors and methods of use thereof
EE200100717A (et) Indasooliühendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ja meetodid nende kasutamiseks
FI973467A (fi) DNA-molekyylejä, valmistus ja käyttö geeniterapiassa
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
DE69822473D1 (de) Lipid-polyamid-konjugate und zusammensetzungen zur verabreichung von nucleinsäuremolekülen
HK1030144A1 (en) Method for treatment of liver tumours and pharmaceutical compositions for use therein.
BR9711296A (pt) Composto processo terap-utico para inibir o crescimento de c-lulas de c ncer e composi-Æo farmac-utica
NO20015828D0 (no) Fremgangsmåter for fremstilling av 5&#39;-nukleinsyre- proteinkonjugater
ZA200007211B (en) Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis.
NO986177D0 (no) FremgangsmÕte for fremstilling av terapeutisk DNA
DK1117661T3 (da) Propanolaminderivater substitueret med heterocycliske grupper, fremgangsmåde til deres fremstilling, farmaceutiske præparater indeholdende disse forbindelser og deres anvendelse
HUP0302913A3 (en) Methods of inducing cancer cell death and tumor regression and preparation of pharmaceutical compositions suitable for treating the same
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
EE200000333A (et) Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod
WO2000078795A3 (en) Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1)
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren

Legal Events

Date Code Title Description
MK1K Patent expired